Radioactive ^(198)Au-Doped Nanostructures with Different Shapes for In Vivo Analyses of Their Biodistribution, Tumor Uptake, and Intratumoral Distribution by Black, Kvar C. L. et al.
Supporting Information for 
 
 
Radioactive 198Au-Doped Nanostructures with Different Shapes for 
in vivo Analyses of Their Biodistribution, Tumor Uptake, and 
Intratumoral Distribution 
 
 
Kvar C. L. Black,†,⊥ Yucai Wang,‡,⊥ Hannah P. Luehmann,† Xin Cai,€ Wenxin Xing,€ Bo Pang,‡ 
Yongfeng Zhao,† Cathy S. Cutler,§ Lihong V. Wang,€ Yongjian Liu,†,* and Younan Xia‡,* 
 
 
 
†Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, 
Missouri 63110, United States 
‡The Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of 
Technology and Emory University, Atlanta, Georgia 30332, United States 
€Department of Biomedical Engineering, Washington University, St. Louis, Missouri 63130, 
United States  
§University of Missouri Research Reactor, Columbia, Missouri 65211, United States 
⊥These two authors contribute equally to this work 
 
 
*Address correspondence to younan.xia@bme.gatech.edu; liuyo@mir.wustl.edu 
 
  
  
 
Figure S1. UV-vis-NIR extinction spectra of the four different types of Au nanostructures: (a) 
nanospheres, (b) nanodisks, (c) nanorods, (d) cubic nanocages. 
  
 Figure S2. Biodistribution of the different types of 198Au-incorporated Au nanostructures at (a) 1 
h, (b) 6 h, and (c) 24 h post injection. The data was presented as %ID/organ. 
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Figure S3. A quantitative comparison of the intensities of Cerenkov luminescence integrated 
from the whole tumor regions after the injection of 198Au-incorporated Au nanospheres, 
nanodisks, nanorods, and cubic nanocages. 
  
  
Figure S4. Cerenkov luminescence images of the organs that were harvested 24 h post injection 
of the 198Au-incorporated (a) nanospheres, (b) nanodisks, (c) nanorods, and (d) cubic nanocages. 
The luminescence images were merged with photographs taken using an ordinary camera. 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S5. Histology of the EMT6 tumor after staining with hematoxylin and eosin (H&E). The 
samples show blood vessels (BVs), individual red blood cells (RBCs) from the leaky 
vasculature, inflammatory cells (ICs), and necrotic regions.  
 
 
  
Figure S6. PET/CT image of a mouse bearing a EMT6 tumor (marked by the elliptic circle) after 
the injection of 64Cu-ATSM. 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
Figure S7. Plots of the hydrodynamic diameter of PEGylated nanostructures as a function of the 
incubation time. The PEGylated nanostructures were incubated with 10% Fetal Bovine Serum 
(FBS) in PBS at 37 ºC for different periods of time. The hydrodynamic diameter was measured 
using dynamic light scattering. 
  
Table S1. A summary of physical parameters for the Au nanostructures used in this study. 
Nanostructures Size (nm) Surface area (nm2) 
198Au radiolabeling specific 
activity (mCi/mg) 
Nanosphere diameter = 56.8 10130 1.6 
Nanodisk 
diameter = 92 
thickness = 7 
13577 0.18 
Nanorod 
length = 39.2 
diameter = 9.1 
1975 2.1 
Nanocage 
edge length = 49.6 
wall thickness = 4.5 
14760 0.34 
 
